Literature DB >> 1537854

Characterization of recombinant rat cathepsin B and nonglycosylated mutants expressed in yeast. New insights into the pH dependence of cathepsin B-catalyzed hydrolyses.

S Hasnain1, T Hirama, A Tam, J S Mort.   

Abstract

The cysteine proteinase rat cathepsin B was expressed in yeast in an active form and was found to be heterogeneously glycosylated at the consensus sequence for N-linked oligosaccharide substitution. Purified enzyme fractions containing the highest levels of glycosylation were shown to have reduced activity. A glycosylation minus mutant constructed by site-directed mutagenesis (by changing the Ser to Ala in the consensus sequence) was still secreted by the yeast and was shown to be functionally identical with purified rat liver cathepsin B. Recombinant cathepsin B was used to further characterize the pH dependence of cathepsin B-catalyzed hydrolyses using 7-amido-4-methylcoumarin (AMC) and p-nitroaniline (pNA) substrates with arginine as the P1, and either arginine or phenylalanine as the P2 residue. The AMC and pNA groups give insights into the leaving group binding site (P') of cathepsin B. These studies show for the first time that at least seven dissociable groups are involved in substrate binding and hydrolysis in cathepsin B activity. Two of these groups, with pKa values of 6.9 and 7.7 in the recombinant enzyme, are in the leaving group binding site and are most likely His110 and His111. The same groups in rat liver cathepsin B have higher pKa values than in recombinant cathepsin B, but have identical function in the two enzymes. Two other groups are probably the active site Cys29 and His199 with pKa values of 3.6 and 8.6, respectively. A group with a pKa of 5.1 interacts with substrates containing Arg at P2, and the group is most likely Glu245. The remaining two groups, one with a pKa of about 4.9 and the other about 5.3, are most likely carboxyl residues possibly interacting with Arg at P1 in the substrate. The possible candidates on the basis of the x-ray structure are Asp22, Asp69, Glu171, and Glu122, all found within a 13 A radius from the active site thiol of Cys29.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537854

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Endolysosomal proteolysis and its regulation.

Authors:  Ché S Pillay; Edith Elliott; Clive Dennison
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

2.  Enzymatic and Structural Characterization of the Major Endopeptidase in the Venus Flytrap Digestion Fluid.

Authors:  Michael W Risør; Line R Thomsen; Kristian W Sanggaard; Tania A Nielsen; Ida B Thøgersen; Marie V Lukassen; Litten Rossen; Irene Garcia-Ferrer; Tibisay Guevara; Carsten Scavenius; Ernst Meinjohanns; F Xavier Gomis-Rüth; Jan J Enghild
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

3.  Expression of functional recombinant human procathepsin B in mammalian cells.

Authors:  W P Ren; R Fridman; J R Zabrecky; L D Morris; N A Day; B F Sloane
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release.

Authors:  David S H Chu; Russell N Johnson; Suzie H Pun
Journal:  J Control Release       Date:  2011-10-20       Impact factor: 9.776

5.  Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.

Authors:  Hanna B Kern; Selvi Srinivasan; Anthony J Convertine; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Pharm       Date:  2017-03-30       Impact factor: 4.939

6.  Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin-B.

Authors:  U I Sires; T M Schmid; C J Fliszar; Z Q Wang; S L Gluck; H G Welgus
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

7.  Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.

Authors:  I Björk; E Pol; E Raub-Segall; M Abrahamson; A D Rowan; J S Mort
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

8.  Demonstration by electrospray mass spectrometry that the peptidyldipeptidase activity of cathepsin B is capable of rat cathepsin B C-terminal processing.

Authors:  A D Rowan; R Feng; Y Konishi; J S Mort
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

9.  Human tumour cathepsin B. Comparison with normal liver cathepsin B.

Authors:  K Moin; N A Day; M Sameni; S Hasnain; T Hirama; B F Sloane
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

10.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.